Aurobindo Pharma

BSE: 524804 | NSE: AUROPHARMA
Aurobindo Pharma (CIN: L24239TG1986PLC015190) operates in the Pharmaceuticals industry and has been listed in the stock market since 6th Apr 1995. It currents trades on NSE with symbol AUROPHARMA and on BSE with scrip code 524804.
The registered office of the company is Plot No.2, Maitrivihar, Ameerpet,Hyderabad,Telangana,500038.

The management team of Aurobindo Pharma is led by Mr. K.Ragunathan who is the Non-Executive - Independent Director-Chairperson. Other members of the management team consist of Santhanam Subramanian (Designation:Chief Financial Officer), Mr. K.Nithyananda Reddy (Designation:Executive Director), Mr. N. Govindarajan (Designation:Executive Director-MD), Mr. M.Sivakumaran (Designation:Executive Director), Mr. M Madan Mohan Reddy (Designation:Executive Director), Mr. P V Ramprasad Reddy (Designation:Non-Executive - Non Independent Director), Mr. M Sitarama Murty (Designation:Non-Executive - Independent Director), Mr. P Sarath Chandra Reddy (Designation:Executive Director), Mrs. Dr Avnit Bimal Singh (Designation:Non-Executive - Independent Director), Mrs. Savita Mahajan (Designation:Non-Executive - Independent Director), B Adi Reddy (Designation:Company Secretary & Compliance Officer), .

The price and other financial information of Aurobindo Pharma is as below -

BSE 796.6 0.05 (0.01%)

BSE

796.6 0.05 (0.01%)
Volume: 2,01,795.00
M. Cap: 46,673.00
P/E: 20.68
Prev. Close: 796.55
Day
52 Wk
Symbol is not Traded Today for NSE

Stock Price Chart

F&O Data

Expiry Date Open Price High Price Low Price Prev Close Last Price Volume Turnover Lacs Underlying Value
29-10-2020 799.85 824.75 797.80 799.40 806.40 5,884.00 62,157.40 802.45
26-11-2020 801.30 826.50 801.30 801.95 809.05 69.00 729.70 802.45
31-12-2020 819.60 820.90 818.50 809.50 818.50 3.00 31.97 802.45
Calls 29 Oct 2020 Puts
OI
(Delta OI)
LTP
(Change)
Intrinsic Value Time Value Strike Price Time Value Intrinsic Value LTP
(Change)
OI
(Delta OI)
-
-
- - 500 - - -
-
-
-
- - 520 - - -
-
-
-
- - 540 - - -
-
-
-
- - 560 - 0 -
1,300
(-)
-
-
- - 580 - - -
-
-
-
- - 600 0.95 0 0.95
(-)
91,000
(-2,600.00)
-
-
- - 620 - - -
-
-
-
- - 640 - - -
-
1,300
(-)
-
136.6 - 660 2.25 0 2.25
(+0.30)
13,000
(+1,300.00)
-
-
- - 680 3.65 0 3.65
(+0.20)
88,400
(-5,200.00)
2,600
(-)
-
96.6 - 700 5.8 0 5.80
(+0.15)
2,61,300
(+6,500.00)
-
-
- - 720 8.4 0 8.40
(-0.75)
3,41,900
(-11,700.00)
44,200
(+1,300.00)
80.00
(+6.00)
56.6 23.4 740 12.6 0 12.60
(-1.20)
1,98,900
(+9,100.00)
1,61,200
(-14,300.00)
62.90
(+2.95)
36.6 26.3 760 18.4 0 18.40
(-1.55)
2,10,600
(-6,500.00)
1,28,700
(-5,200.00)
52.05
(+4.75)
16.6 35.45 780 26.25 0 26.25
(-1.90)
2,41,800
(+13,000.00)
5,99,300
(-1,19,600.00)
41.10
(+3.65)
0 41.1 800 31.9 3.4 35.30
(-2.55)
3,21,100
(-14,300.00)
4,75,800
(+1,15,700.00)
31.50
(+2.60)
0 31.5 820 22.05 23.4 45.45
(-6.90)
85,800
(+16,900.00)
3,77,000
(+28,600.00)
24.00
(+1.95)
0 24 840 13.6 43.4 57.00
(-18.55)
1,06,600
(-)
3,09,400
(+15,600.00)
19.25
(+2.50)
0 19.25 860 6.6 63.4 70.00
(-14.40)
16,900
(-)
1,71,600
(-1,300.00)
13.85
(+1.00)
0 13.85 880 - 83.4 -
2,600
(-)
5,39,500
(-7,800.00)
10.45
(+0.60)
0 10.45 900 4.3 103.4 107.70
(-1.05)
11,700
(-1,300.00)
91,000
(+5,200.00)
8.40
(+0.95)
0 8.4 920 - 123.4 -
2,600
(-)
39,000
(+3,900.00)
6.05
(+0.55)
0 6.05 940 - 143.4 -
2,600
(-)
31,200
(+11,700.00)
5.00
(+0.90)
0 5 960 - 163.4 -
1,300
(-)
-
-
- - 980 - - -
-
3,77,000
(+22,100.00)
3.35
(+0.45)
0 3.35 1,000 - - -
-
10,400
(-)
2.95
(+1.30)
0 2.95 1,020 - - -
-
3,900
(-)
3.00
(+1.45)
0 3 1,040 - - -
-
-
-
- - 1,060 - - -
-
-
-
- - 1,080 - - -
-
1,300
(-)
-
0 - 1,100 - - -
-

Shareholding Pattern

Category No. of shares Percent(%)
Promoters 28,67,65,471 48.94
Foreign Institutions 13,25,73,949 22.63
NBFC and Mutual Funds 7,15,00,458 12.20
Others 2,63,77,719 4.50
General Public 4,86,00,880 8.29
Financial Institutions 21,20,132 0.36
ForeignPromoter 1,80,00,000 3.07
Total 58,59,38,609 99.99

Financial Data

Consolidated
Figures in crore 2020 2019 2018
Net Sales 23,098.51 19,563.55 16,463.03
Operating Profit 5,014.88 4,021.90 3,876.87
Other Income 191.87 158.02 105.12
Interest 305.13 262.60 77.72
Depreciation 966.71 667.95 557.97
Profit Before Tax 3,743.04 3,091.35 3,241.18
Tax 913.52 726.85 818.27
Profit After Tax 2,829.52 2,364.50 2,422.91
Share Capital 58.59 58.59 58.59
Reserves 16,751.79 13,832.19 11,621.83
Net Worth 16,810.38 13,890.78 11,680.42
Loans 5,988.57 7,046.92 4,836.36
Gross Block 12,441.26 10,497.62 7,894.78
Investments 554.71 360.22 311.54
Cash 2,842.15 1,957.18 1,262.25
Debtors 4,315.15 3,413.78 3,080.20
Net Working Capital 10,861.97 10,435.76 8,103.34
Operating Profit Margin (%) 21.71 20.56 23.55
Net Profit Margin (%) 12.25 12.09 14.72
Earning Per Share (Rs) 48.32 40.36 41.36
Dividend (%) 300.00 250.00 250.00
Dividend Payout 175.78 146.48 219.71
Standalone
Figures in crore 2020 2019 2018
Net Sales 13,266.48 12,257.89 10,269.90
Operating Profit 3,089.12 2,608.51 2,750.66
Other Income 403.37 199.22 80.65
Interest 240.94 230.86 52.89
Depreciation 470.48 413.03 354.83
Profit Before Tax 2,377.70 1,964.62 2,342.94
Tax 504.96 434.89 530.17
Profit After Tax 1,872.74 1,529.73 1,812.77
Share Capital 58.59 58.59 58.59
Reserves 12,966.97 11,292.03 9,923.99
Net Worth 13,025.56 11,350.62 9,982.58
Loans 3,783.90 4,542.44 3,752.60
Gross Block 6,115.18 5,446.15 4,292.18
Investments 2,519.70 2,339.06 1,967.50
Cash 78.25 75.77 245.90
Debtors 5,789.57 5,232.07 4,468.23
Net Working Capital 9,198.45 8,615.29 7,230.73
Operating Profit Margin (%) 23.29 21.28 26.78
Net Profit Margin (%) 14.12 12.48 17.65
Earning Per Share (Rs) 31.96 26.11 30.94
Dividend (%) 300.00 250.00 250.00
Dividend Payout 175.78 146.48 219.71
Dividend Declared (₹)
The company has declared dividend 30 times between 12 Sep 2001 and 21 Aug 2020, totaling Rs. 40.00 so far. The most recent dividend was declared on 21 Aug 2020 for Rs. 1.25.
Bonus History
Date Ratio
20 Jul 2015 issue 1:1

Financial Data Graph

The peers of Aurobindo Pharma are DRREDDY, CIPLA and SUNPHARMA*. You can get more detailed information on those company by clicking on the respective names.

* The above data is collected from public sources and we do not guarantee the accuracy of the same.*

Popular Comments

No comment posted for this article.